TNS3 and chronic myelogenous leukemia, BCR-ABL1 positive: By comparison, Gamitrinib was a more potent inhibitor of oxidative bioenergetics than H71-TPP, and indistinguishably suppressed OCR in AML or CML cell types in a concentration-dependent manner (Figure 5B).